Edge Therapeutics (EDGE) Reports Q3 Loss of $7.08
Edge Therapeutics (NASDAQ: EDGE) reported Q3 EPS of ($7.08), versus ($2.30) reported last year.
For earnings history and earnings-related data on Edge Therapeutics (EDGE) click here.
Edge Therapeutics (NASDAQ: EDGE) reported Q3 EPS of ($7.08), versus ($2.30) reported last year.
For earnings history and earnings-related data on Edge Therapeutics (EDGE) click here.